In contrast, in mice implanted with GRP78‐Mut‐Cys420 THP‐1 cells, NaHS treatment had no significant effect on tumor growth rates (P = 0.8849, Figure 6L, 6 m, Figure S5C, Supporting Information) or survival times (P = 0.9937, Figure 6N). This evidence concerns the gene HSPA5 and neoplasm.